February 10-11, 2014
The Waldorf Astoria, New York
Where biotech's elite
engages the Street.
Now in its 16th year, the BIO CEO & Investor Conference is the exclusive forum where institutional investors,
research analysts and senior industry executives come to discuss trends, attend company presentations,
conduct 1x1 meetings and learn about investment opportunities within the biotechnology industry.
Fireside Chats
Leonard Bell, MD, CEO, Alexion Pharmaceuticals
Belén Garijo, MD, President and CEO, Merck Serono
Richard F. Pops, Chairman and CEO, Alkermes plc
David E.I. Pyott, Chairman of the Board and CEO, Allergan
Christopher A. Viehbacher, CEO, Sanof; Chairman, Genzyme
Plenary Sessions
Opening Plenary: A Room with a (Buy-Side) View: The Year Ahead
Closing Plenary: Fundraising in the New Capital Market Environment
High-Caliber Business and Therapeutic Program Sessions
Business Roundtables:
The Reimbursement Landscape Under ACA
Deal-Making Game Theory
Solution Development: Aiming the Whole Pipeline at a Single Goal
Therapeutic Workshops:
Delivering the [RNAi] Goods
Keeping an "I" on Oncology: The ASCO Immunotherapy Preview
Rare Diseases: Dissecting the Myths
Register today at bio.org/ceo
Complimentary registration for qualifed investors
A Vital Business Catalyst.
To learn more about BIO's portfolio
of global events, visit bio.org/events